{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T03:35:47Z","timestamp":1789788947777,"version":"4.0.1"},"reference-count":202,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,3]]},"DOI":"10.7759\/cureus.63775","type":"journal-article","created":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T02:45:59Z","timestamp":1720061159000},"source":"Crossref","is-referenced-by-count":14,"title":["Role of Nonalcoholic Fatty Liver Disease in Periodontitis: A Bidirectional Relationship"],"prefix":"10.7759","author":[{"given":"Hardika S","family":"Vegda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavin","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav A","family":"Girdhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd. Shabankhan H","family":"Pathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahnuma","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mainul","family":"Haque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susmita","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/ma11101802","article-title":"Oral microbes, biofilms and their role in periodontal and peri-implant diseases","volume":"11","author":"Lasserre JF","year":"2018","unstructured":"Lasserre JF, Brecx MC, Toma S. Oral microbes, biofilms and their role in periodontal and peri-implant diseases. Materials (Basel). 2018, 11:1802. 10.3390\/ma11101802","journal-title":"Materials (Basel)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1080\/20002297.2023.2197779","article-title":"Current concepts in the pathogenesis of periodontitis: from symbiosis to dysbiosis","volume":"15","author":"Abdulkareem AA","year":"2023","unstructured":"Abdulkareem AA, Al-Taweel FB, Al-Sharqi AJ, Gul SS, Sha A, Chapple IL. Current concepts in the pathogenesis of periodontitis: from symbiosis to dysbiosis. J Oral Microbiol. 2023, 15:2197779. 10.1080\/20002297.2023.2197779","journal-title":"J Oral Microbiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.bj.2018.12.001","article-title":"Association between periodontal pathogens and systemic disease","volume":"42","author":"Bui FQ","year":"2019","unstructured":"Bui FQ, Almeida-da-Silva CL, Huynh B, et al.. Association between periodontal pathogens and systemic disease. Biomed J. 2019, 42:27-35. 10.1016\/j.bj.2018.12.001","journal-title":"Biomed J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13040681","article-title":"The bidirectional relationship between periodontal disease and diabetes mellitus-a review","volume":"13","author":"P\u0103unic\u0103 I","year":"2023","unstructured":"P\u0103unic\u0103 I, Giurgiu M, Dumitriu AS, P\u0103unic\u0103 S, Pantea Stoian AM, Martu MA, Serafinceanu C. The bidirectional relationship between periodontal disease and diabetes mellitus-a review. Diagnostics (Basel). 2023, 13:681. 10.3390\/diagnostics13040681","journal-title":"Diagnostics (Basel)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12206442","article-title":"Factors associated with periodontitis in younger individuals: a scoping review","volume":"12","author":"Hung M","year":"2023","unstructured":"Hung M, Kelly R, Mohajeri A, et al.. Factors associated with periodontitis in younger individuals: a scoping review. J Clin Med. 2023, 12:6442. 10.3390\/jcm12206442","journal-title":"J Clin Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00784-021-04263-2","article-title":"Psychopathologies and socioeconomic status as risk indicators for periodontitis: a survey-based investigation in German dental practices","volume":"26","author":"Lenk M","year":"2022","unstructured":"Lenk M, Noack B, Weidner K, Lorenz K. Psychopathologies and socioeconomic status as risk indicators for periodontitis: a survey-based investigation in German dental practices. Clin Oral Investig. 2022, 26:2853-62. 10.1007\/s00784-021-04263-2","journal-title":"Clin Oral Investig"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdsr.2021.09.005","article-title":"Mechanism of alveolar bone destruction in periodontitis-periodontal bacteria and inflammation","volume":"57","author":"Usui M","year":"2021","unstructured":"Usui M, Onizuka S, Sato T, Kokabu S, Ariyoshi W, Nakashima K. Mechanism of alveolar bone destruction in periodontitis-periodontal bacteria and inflammation. Jpn Dent Sci Rev. 2021, 57:201-8. 10.1016\/j.jdsr.2021.09.005","journal-title":"Jpn Dent Sci Rev"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/s41415-023-6055-7","article-title":"Patient-reported understanding and dentist-reported management of periodontal diseases-a survey: do you know what gum disease is?","volume":"235","author":"Rana H","year":"2023","unstructured":"Rana H, Warnes B, Davies M, West NX. Patient-reported understanding and dentist-reported management of periodontal diseases-a survey: do you know what gum disease is?. Br Dent J. 2023, 235:127-31. 10.1038\/s41415-023-6055-7","journal-title":"Br Dent J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/jcpe.13189","article-title":"Periodontitis and cardiovascular diseases: consensus report","volume":"47","author":"Sanz M","year":"2020","unstructured":"Sanz M, Marco Del Castillo A, Jepsen S, et al.. Periodontitis and cardiovascular diseases: consensus report. J Clin Periodontol. 2020, 47:268-88. 10.1111\/jcpe.13189","journal-title":"J Clin Periodontol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.617485","article-title":"Dysbiosis from a microbial and host perspective relative to oral health and disease","volume":"12","author":"Cugini C","year":"2021","unstructured":"Cugini C, Ramasubbu N, Tsiagbe VK, Fine DH. Dysbiosis from a microbial and host perspective relative to oral health and disease. Front Microbiol. 2021, 12:617485. 10.3389\/fmicb.2021.617485","journal-title":"Front Microbiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2021.1979882","article-title":"Pathobionts: mechanisms of survival, expansion, and interaction with host with a focus on Clostridioides difficile","volume":"13","author":"Chandra H","year":"2021","unstructured":"Chandra H, Sharma KK, Tuovinen OH, Sun X, Shukla P. Pathobionts: mechanisms of survival, expansion, and interaction with host with a focus on Clostridioides difficile. Gut Microbes. 2021, 13:1979882. 10.1080\/19490976.2021.1979882","journal-title":"Gut Microbes"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/JPER.21-0120","article-title":"Dysbiosis revisited: understanding the role of the oral microbiome in the pathogenesis of gingivitis and periodontitis: a critical assessment","volume":"92","author":"Scannapieco FA","year":"2021","unstructured":"Scannapieco FA, Dongari-Bagtzoglou A. Dysbiosis revisited: understanding the role of the oral microbiome in the pathogenesis of gingivitis and periodontitis: a critical assessment. J Periodontol. 2021, 92:1071-8. 10.1002\/JPER.21-0120","journal-title":"J Periodontol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2020.04.011","article-title":"Label or concept-what is a pathobiont?","volume":"28","author":"Jochum L","year":"2020","unstructured":"Jochum L, Stecher B. Label or concept-what is a pathobiont?. Trends Microbiol. 2020, 28:789-92. 10.1016\/j.tim.2020.04.011","journal-title":"Trends Microbiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.814177","article-title":"The role of the oral microbiota related to periodontal diseases in anxiety, mood and trauma- and stress-related disorders","volume":"12","author":"Mart\u00ednez M","year":"2021","unstructured":"Mart\u00ednez M, Postolache TT, Garc\u00eda-Bueno B, Leza JC, Figuero E, Lowry CA, Malan-M\u00fcller S. The role of the oral microbiota related to periodontal diseases in anxiety, mood and trauma- and stress-related disorders. Front Psychiatry. 2021, 12:814177. 10.3389\/fpsyt.2021.814177","journal-title":"Front Psychiatry"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1177\/15353702231187645","article-title":"Oral microbiota in human health and disease: a perspective","volume":"248","author":"Santacroce L","year":"2023","unstructured":"Santacroce L, Passarelli PC, Azzolino D, et al.. Oral microbiota in human health and disease: a perspective. Exp Biol Med (Maywood). 2023, 248:1288-301. 10.1177\/15353702231187645","journal-title":"Exp Biol Med (Maywood)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9030496","article-title":"Interconnections between the oral and gut microbiomes: reversal of microbial dysbiosis and the balance between systemic health and disease","volume":"9","author":"Khor B","year":"2021","unstructured":"Khor B, Snow M, Herrman E, et al.. Interconnections between the oral and gut microbiomes: reversal of microbial dysbiosis and the balance between systemic health and disease. Microorganisms. 2021, 9:496. 10.3390\/microorganisms9030496","journal-title":"Microorganisms"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1093967","article-title":"Regulatory effects of oral microbe on intestinal microbiota and the illness","volume":"13","author":"Lu Y","year":"2023","unstructured":"Lu Y, Li Z, Peng X. Regulatory effects of oral microbe on intestinal microbiota and the illness. Front Cell Infect Microbiol. 2023, 13:1093967. 10.3389\/fcimb.2023.1093967","journal-title":"Front Cell Infect Microbiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s12937-023-00856-7","article-title":"The role of the oral microbiome in obesity and metabolic disease: potential systemic implications and effects on taste perception","volume":"22","author":"Schamarek I","year":"2023","unstructured":"Schamarek I, Anders L, Chakaroun RM, Kovacs P, Rohde-Zimmermann K. The role of the oral microbiome in obesity and metabolic disease: potential systemic implications and effects on taste perception. Nutr J. 2023, 22:28. 10.1186\/s12937-023-00856-7","journal-title":"Nutr J"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/s41522-024-00476-x","article-title":"Nisin lantibiotic prevents NAFLD liver steatosis and mitochondrial oxidative stress following periodontal disease by abrogating oral, gut and liver dysbiosis","volume":"10","author":"Kuraji R","year":"2024","unstructured":"Kuraji R, Ye C, Zhao C, et al.. Nisin lantibiotic prevents NAFLD liver steatosis and mitochondrial oxidative stress following periodontal disease by abrogating oral, gut and liver dysbiosis. NPJ Biofilms Microbiomes. 2024, 10:3. 10.1038\/s41522-024-00476-x","journal-title":"NPJ Biofilms Microbiomes"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1128\/JB.00542-10","article-title":"The human oral microbiome","volume":"192","author":"Dewhirst FE","year":"2010","unstructured":"Dewhirst FE, Chen T, Izard J, et al.. The human oral microbiome. J Bacteriol. 2010, 192:10.1128\/JB.00542-10","journal-title":"J Bacteriol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.43.11.5721-5732.2005","article-title":"Defining the normal bacterial flora of the oral cavity","volume":"43","author":"Aas JA","year":"2005","unstructured":"Aas JA, Paster BJ, Stokes LN, Olsen I, Dewhirst FE. Defining the normal bacterial flora of the oral cavity. J Clin Microbiol. 2005, 43:5721-32. 10.1128\/JCM.43.11.5721-5732.2005","journal-title":"J Clin Microbiol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.sjbs.2021.08.096","article-title":"Isolation and identification of the oral bacteria and their characterization for bacteriocin production in the oral cavity","volume":"29","author":"Alghamdi S","year":"2022","unstructured":"Alghamdi S. Isolation and identification of the oral bacteria and their characterization for bacteriocin production in the oral cavity. Saudi J Biol Sci. 2022, 29:318-23. 10.1016\/j.sjbs.2021.08.096","journal-title":"Saudi J Biol Sci"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031372","article-title":"A narrative review on oral and periodontal bacteria microbiota photobiomodulation, through visible and near-infrared light: from the origins to modern therapies","volume":"23","author":"Amaroli A","year":"2022","unstructured":"Amaroli A, Ravera S, Zekiy A, Benedicenti S, Pasquale C. A narrative review on oral and periodontal bacteria microbiota photobiomodulation, through visible and near-infrared light: from the origins to modern therapies. Int J Mol Sci. 2022, 23:1372. 10.3390\/ijms23031372","journal-title":"Int J Mol Sci"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-020-01801-y","article-title":"Defining the oral microbiome by whole-genome sequencing and resistome analysis: the complexity of the healthy picture","volume":"20","author":"Caselli E","year":"2020","unstructured":"Caselli E, Fabbri C, D'Accolti M, Soffritti I, Bassi C, Mazzacane S, Franchi M. Defining the oral microbiome by whole-genome sequencing and resistome analysis: the complexity of the healthy picture. BMC Microbiol. 2020, 20:120. 10.1186\/s12866-020-01801-y","journal-title":"BMC Microbiol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1080\/089106000750051800","article-title":"Role of the oral microflora in health","volume":"12","author":"Marsh PD","year":"2000","unstructured":"Marsh PD. Role of the oral microflora in health. Microb Ecol Health Dis. 2000, 12:130-7. 10.1080\/089106000750051800","journal-title":"Microb Ecol Health Dis"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms11092307","article-title":"Oral microbiota: the influences and interactions of saliva, IgA, and dietary factors in health and disease","volume":"11","author":"Nagakubo D","year":"2023","unstructured":"Nagakubo D, Kaibori Y. Oral microbiota: the influences and interactions of saliva, IgA, and dietary factors in health and disease. Microorganisms. 2023, 11:2307. 10.3390\/microorganisms11092307","journal-title":"Microorganisms"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.csbj.2021.02.010","article-title":"The oralome and its dysbiosis: new insights into oral microbiome-host interactions","volume":"19","author":"Radaic A","year":"2021","unstructured":"Radaic A, Kapila YL. The oralome and its dysbiosis: new insights into oral microbiome-host interactions. Comput Struct Biotechnol J. 2021, 19:1335-60. 10.1016\/j.csbj.2021.02.010","journal-title":"Comput Struct Biotechnol J"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.4103\/jomfp.JOMFP_304_18","article-title":"Oral microbiome: unveiling the fundamentals","volume":"23","author":"Deo PN","year":"2019","unstructured":"Deo PN, Deshmukh R. Oral microbiome: unveiling the fundamentals. J Oral Maxillofac Pathol. 2019, 23:122-8. 10.4103\/jomfp.JOMFP_304_18","journal-title":"J Oral Maxillofac Pathol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1111\/adj.12565","article-title":"Studying the human oral microbiome: challenges and the evolution of solutions","volume":"63","author":"Benn A","year":"2018","unstructured":"Benn A, Heng N, Broadbent JM, Thomson WM. Studying the human oral microbiome: challenges and the evolution of solutions. Aust Dent J. 2018, 63:14-24. 10.1111\/adj.12565","journal-title":"Aust Dent J"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)01387-9","article-title":"The human mouth as a focus of infection","volume":"138","author":"Miller WD","year":"1891","unstructured":"Miller WD. The human mouth as a focus of infection. Lancet. 1891, 138:340-342. 10.1016\/S0140-6736(02)01387-9","journal-title":"Lancet"},{"key":"ref31","article-title":"The micro-organisms of the human mouth: the local and general diseases which are caused by them","author":"Miller WD","year":"1890","unstructured":"Miller WD. The micro-organisms of the human mouth: the local and general diseases which are caused by them. Karger, Basel, Switzerland; 1890."},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1913.04350110001001","article-title":"Chronic focal infection as a causative factor in chronic arthritis","volume":"61","author":"Billings F","year":"1913","unstructured":"Billings F. Chronic focal infection as a causative factor in chronic arthritis. JAMA. 1913, 61:819-22. 10.1001\/jama.1913.04350110001001","journal-title":"JAMA"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2020.620254","article-title":"The oral microbiome in pediatric IBD: a source of pathobionts or biomarkers?","volume":"8","author":"Elmaghrawy K","year":"2020","unstructured":"Elmaghrawy K, Hussey S, Moran GP. The oral microbiome in pediatric IBD: a source of pathobionts or biomarkers?. Front Pediatr. 2020, 8:620254. 10.3389\/fped.2020.620254","journal-title":"Front Pediatr"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1038\/s41522-024-00511-x","article-title":"Integrative analysis reveals associations between oral microbiota dysbiosis and host genetic and epigenetic aberrations in oral cavity squamous cell carcinoma","volume":"10","author":"Cai L","year":"2024","unstructured":"Cai L, Zhu H, Mou Q, et al.. Integrative analysis reveals associations between oral microbiota dysbiosis and host genetic and epigenetic aberrations in oral cavity squamous cell carcinoma. NPJ Biofilms Microbiomes. 2024, 10:39. 10.1038\/s41522-024-00511-x","journal-title":"NPJ Biofilms Microbiomes"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.614448","article-title":"Dysbiosis of oral microbiota during oral squamous cell carcinoma development","volume":"11","author":"Sarkar P","year":"2021","unstructured":"Sarkar P, Malik S, Laha S, et al.. Dysbiosis of oral microbiota during oral squamous cell carcinoma development. Front Oncol. 2021, 11:614448. 10.3389\/fonc.2021.614448","journal-title":"Front Oncol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1080\/10408398.2022.2140330","article-title":"Is oral microbiota associated with overweight and obesity in children and adolescents? A systematic review","volume":"64","author":"de Lemos GM","year":"2024","unstructured":"de Lemos GM, Resende CM, Campello CP, et al.. Is oral microbiota associated with overweight and obesity in children and adolescents? A systematic review. Crit Rev Food Sci Nutr. 2024, 64:4275-85. 10.1080\/10408398.2022.2140330","journal-title":"Crit Rev Food Sci Nutr"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-216972","article-title":"Dysbiosis in the oral microbiomes of anti-CCP positive individuals at risk of developing rheumatoid arthritis","volume":"80","author":"Cheng Z","year":"2021","unstructured":"Cheng Z, Do T, Mankia K, et al.. Dysbiosis in the oral microbiomes of anti-CCP positive individuals at risk of developing rheumatoid arthritis. Ann Rheum Dis. 2021, 80:162-8. 10.1136\/annrheumdis-2020-216972","journal-title":"Ann Rheum Dis"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11070625","article-title":"Exploring the oral microbiome in rheumatic diseases, state of art and future prospective in personalized medicine with an AI approach","volume":"11","author":"Bellando-Randone S","year":"2021","unstructured":"Bellando-Randone S, Russo E, Venerito V, Matucci-Cerinic M, Iannone F, Tangaro S, Amedei A. Exploring the oral microbiome in rheumatic diseases, state of art and future prospective in personalized medicine with an AI approach. J Pers Med. 2021, 11:625. 10.3390\/jpm11070625","journal-title":"J Pers Med"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23095142","article-title":"Impact of oral microbiome in periodontal health and periodontitis: a critical review on prevention and treatment","volume":"23","author":"Di Stefano M","year":"2022","unstructured":"Di Stefano M, Polizzi A, Santonocito S, Romano A, Lombardi T, Isola G. Impact of oral microbiome in periodontal health and periodontitis: a critical review on prevention and treatment. Int J Mol Sci. 2022, 23:5142. 10.3390\/ijms23095142","journal-title":"Int J Mol Sci"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1111\/eos.12423","article-title":"Mediators between oral dysbiosis and cardiovascular diseases","volume":"126","author":"Pieti\u00e4inen M","year":"2018","unstructured":"Pieti\u00e4inen M, Liljestrand JM, Kopra E, Pussinen PJ. Mediators between oral dysbiosis and cardiovascular diseases. Eur J Oral Sci. 2018, 126:26-36. 10.1111\/eos.12423","journal-title":"Eur J Oral Sci"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1010368","article-title":"The oral microbiota and cardiometabolic health: a comprehensive review and emerging insights","volume":"13","author":"Li Y","year":"2022","unstructured":"Li Y, Zhu M, Liu Y, et al.. The oral microbiota and cardiometabolic health: a comprehensive review and emerging insights. Front Immunol. 2022, 13:1010368. 10.3389\/fimmu.2022.1010368","journal-title":"Front Immunol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.579766","article-title":"Preterm birth is correlated with increased oral originated microbiome in the gut","volume":"11","author":"Yin C","year":"2021","unstructured":"Yin C, Chen J, Wu X, et al.. Preterm birth is correlated with increased oral originated microbiome in the gut. Front Cell Infect Microbiol. 2021, 11:579766. 10.3389\/fcimb.2021.579766","journal-title":"Front Cell Infect Microbiol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms11102550","article-title":"Oral microbiome and Alzheimer's disease","volume":"11","author":"Wan J","year":"2023","unstructured":"Wan J, Fan H. Oral microbiome and Alzheimer's disease. Microorganisms. 2023, 11:2550. 10.3390\/microorganisms11102550","journal-title":"Microorganisms"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1038\/s41368-022-00163-7","article-title":"Oral microbiota in human systematic diseases","volume":"14","author":"Peng X","year":"2022","unstructured":"Peng X, Cheng L, You Y, et al.. Oral microbiota in human systematic diseases. Int J Oral Sci. 2022, 14:14. 10.1038\/s41368-022-00163-7","journal-title":"Int J Oral Sci"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11081376","article-title":"Oral microbiota: a major player in the diagnosis of systemic diseases","volume":"11","author":"Thomas C","year":"2021","unstructured":"Thomas C, Minty M, Vinel A, et al.. Oral microbiota: a major player in the diagnosis of systemic diseases. Diagnostics (Basel). 2021, 11:1376. 10.3390\/diagnostics11081376","journal-title":"Diagnostics (Basel)"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.643913","article-title":"Oral pathogen Fusobacterium nucleatum coaggregates with Pseudomonas aeruginosa to modulate the inflammatory cytotoxicity of pulmonary epithelial cells","volume":"11","author":"Li Q","year":"2021","unstructured":"Li Q, Wang H, Tan L, Zhang S, Lin L, Tang X, Pan Y. Oral pathogen Fusobacterium nucleatum coaggregates with Pseudomonas aeruginosa to modulate the inflammatory cytotoxicity of pulmonary epithelial cells. Front Cell Infect Microbiol. 2021, 11:643913. 10.3389\/fcimb.2021.643913","journal-title":"Front Cell Infect Microbiol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12010114","article-title":"Local and systemic antibiotics in peri-implantitis management: an umbrella review","volume":"12","author":"Boccia G","year":"2023","unstructured":"Boccia G, Di Spirito F, D'Ambrosio F, Di Palo MP, Giordano F, Amato M. Local and systemic antibiotics in peri-implantitis management: an umbrella review. Antibiotics (Basel). 2023, 12:114. 10.3390\/antibiotics12010114","journal-title":"Antibiotics (Basel)"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2022.0365","article-title":"Global incidence and prevalence of nonalcoholic fatty liver disease","volume":"29","author":"Teng ML","year":"2023","unstructured":"Teng ML, Ng CH, Huang DQ, et al.. Global incidence and prevalence of nonalcoholic fatty liver disease. Clin Mol Hepatol. 2023, 29:S32-42. 10.3350\/cmh.2022.0365","journal-title":"Clin Mol Hepatol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2022.0424","article-title":"Non-alcoholic fatty liver disease: definition and subtypes","volume":"29","author":"Han SK","year":"2023","unstructured":"Han SK, Baik SK, Kim MY. Non-alcoholic fatty liver disease: definition and subtypes. Clin Mol Hepatol. 2023, 29:S5-16. 10.3350\/cmh.2022.0424","journal-title":"Clin Mol Hepatol"},{"key":"ref50","article-title":"Nonalcoholic fatty liver disease","volume":"8","author":"Schaffner F","year":"1986","unstructured":"Schaffner F, Thaler H. Nonalcoholic fatty liver disease. Prog Liver Dis. 1986, 8:283-98.","journal-title":"Prog Liver Dis"},{"key":"ref51","doi-asserted-by":"crossref","DOI":"10.1016\/S0025-6196(24)00530-5","article-title":"Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease","volume":"55","author":"Ludwig J","year":"1980","unstructured":"Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc. 1980, 55:434-8.","journal-title":"Mayo Clin Proc"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S386982","article-title":"Biological mechanisms and related natural inhibitors of CD36 in nonalcoholic fatty liver","volume":"16","author":"Feng Y","year":"2022","unstructured":"Feng Y, Sun W, Sun F, et al.. Biological mechanisms and related natural inhibitors of CD36 in nonalcoholic fatty liver. Drug Des Devel Ther. 2022, 16:3829-45. 10.2147\/DDDT.S386982","journal-title":"Drug Des Devel Ther"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-018-2947-0","article-title":"Molecular pathways of nonalcoholic fatty liver disease development and progression","volume":"76","author":"Bessone F","year":"2019","unstructured":"Bessone F, Razori MV, Roma MG. Molecular pathways of nonalcoholic fatty liver disease development and progression. Cell Mol Life Sci. 2019, 76:99-128. 10.1007\/s00018-018-2947-0","journal-title":"Cell Mol Life Sci"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.02.066","article-title":"Pathogenesis of nonalcoholic steatohepatitis","volume":"150","author":"Machado MV","year":"2016","unstructured":"Machado MV, Diehl AM. Pathogenesis of nonalcoholic steatohepatitis. Gastroenterology. 2016, 150:1769-77. 10.1053\/j.gastro.2016.02.066","journal-title":"Gastroenterology"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00358.2018","article-title":"Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals","volume":"316","author":"Suppli MP","year":"2019","unstructured":"Suppli MP, Rigbolt KT, Veidal SS, et al.. Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals. Am J Physiol Gastrointest Liver Physiol. 2019, 316:G462-72. 10.1152\/ajpgi.00358.2018","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam M","year":"2020","unstructured":"Eslam M, Newsome PN, Sarin SK, et al.. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020, 73:202-9. 10.1016\/j.jhep.2020.03.039","journal-title":"J Hepatol"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(22)00127-3","article-title":"Promoting the term MAFLD: China in action","volume":"7","author":"Zhang XL","year":"2022","unstructured":"Zhang XL, Fan JG, Wei L, Shi JP, Zheng MH; Chinese MAFLD Clinical Research Network. Promoting the term MAFLD: China in action. Lancet Gastroenterol Hepatol. 2022, 7:598. 10.1016\/S2468-1253(22)00127-3","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.15009","article-title":"Nonalcoholic fatty liver disease burden: Australia, 2019-2030","volume":"35","author":"Adams LA","year":"2020","unstructured":"Adams LA, Roberts SK, Strasser SI, et al.. Nonalcoholic fatty liver disease burden: Australia, 2019-2030. J Gastroenterol Hepatol. 2020, 35:1628-35. 10.1111\/jgh.15009","journal-title":"J Gastroenterol Hepatol"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajg.2023.09.005","article-title":"Non-alcoholic fatty liver disease and periodontal disease: a systematic review and meta-analysis of cross-sectional studies","volume":"24","author":"Aguiar IL","year":"2023","unstructured":"Aguiar IL, Santos-Lins LS, Brasil-Oliveira R, Cotrim HP, Lins-Kusterer L. Non-alcoholic fatty liver disease and periodontal disease: a systematic review and meta-analysis of cross-sectional studies. Arab J Gastroenterol. 2023, 24:198-203. 10.1016\/j.ajg.2023.09.005","journal-title":"Arab J Gastroenterol"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1111\/jcpe.13341","article-title":"Association between periodontal disease, tooth loss and liver diseases risk","volume":"47","author":"Chen Y","year":"2020","unstructured":"Chen Y, Yang YC, Zhu BL, Wu CC, Lin RF, Zhang X. Association between periodontal disease, tooth loss and liver diseases risk. J Clin Periodontol. 2020, 47:1053-63. 10.1111\/jcpe.13341","journal-title":"J Clin Periodontol"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000037185","article-title":"Diagnostic value of sphingolipid metabolism-related genes CD37 and CXCL9 in nonalcoholic fatty liver disease","volume":"103","author":"Zhang J","year":"2024","unstructured":"Zhang J, Wang L, Jiang M. Diagnostic value of sphingolipid metabolism-related genes CD37 and CXCL9 in nonalcoholic fatty liver disease. Medicine (Baltimore). 2024, 103:e37185. 10.1097\/MD.0000000000037185","journal-title":"Medicine (Baltimore)"},{"key":"ref62","unstructured":"BioRender. (2024). Accessed. June 20, 2024: https:\/\/www.biorender.com\/."},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06318-7","article-title":"Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations","volume":"9","author":"MacParland SA","year":"2018","unstructured":"MacParland SA, Liu JC, Ma XZ, et al.. Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations. Nat Commun. 2018, 9:4383. 10.1038\/s41467-018-06318-7","journal-title":"Nat Commun"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2011.08.025","article-title":"The interaction of hepatic lipid and glucose metabolism in liver diseases","volume":"56","author":"Bechmann LP","year":"2012","unstructured":"Bechmann LP, Hannivoort RA, Gerken G, Hotamisligil GS, Trauner M, Canbay A. The interaction of hepatic lipid and glucose metabolism in liver diseases. J Hepatol. 2012, 56:952-64. 10.1016\/j.jhep.2011.08.025","journal-title":"J Hepatol"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1007\/BF01797915","article-title":"Detoxification pathways in the liver","volume":"14","author":"Grant DM","year":"1991","unstructured":"Grant DM. Detoxification pathways in the liver. J Inherit Metab Dis. 1991, 14:421-30. 10.1007\/BF01797915","journal-title":"J Inherit Metab Dis"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1016\/j.cub.2017.09.019","article-title":"The liver","volume":"27","author":"Trefts E","year":"2017","unstructured":"Trefts E, Gannon M, Wasserman DH. The liver. Curr Biol. 2017, 27:R1147-51. 10.1016\/j.cub.2017.09.019","journal-title":"Curr Biol"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000002690","article-title":"Immune cell trafficking to the liver","volume":"103","author":"Chaudhry S","year":"2019","unstructured":"Chaudhry S, Emond J, Griesemer A. Immune cell trafficking to the liver. Transplantation. 2019, 103:1323-37. 10.1097\/TP.0000000000002690","journal-title":"Transplantation"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1177\/1091581819898399","article-title":"Beyond metabolism: role of the immune system in hepatic toxicity","volume":"39","author":"Hastings KL","year":"2020","unstructured":"Hastings KL, Green MD, Gao B, Ganey PE, Roth RA, Burleson GR. Beyond metabolism: role of the immune system in hepatic toxicity. Int J Toxicol. 2020, 39:151-64. 10.1177\/1091581819898399","journal-title":"Int J Toxicol"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2015.97","article-title":"Hepatocytes: a key cell type for innate immunity","volume":"13","author":"Zhou Z","year":"2016","unstructured":"Zhou Z, Xu MJ, Gao B. Hepatocytes: a key cell type for innate immunity. Cell Mol Immunol. 2016, 13:301-15. 10.1038\/cmi.2015.97","journal-title":"Cell Mol Immunol"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1007\/s43152-021-00030-3","article-title":"Extracellular matrix remodeling in chronic liver disease","volume":"2","author":"Ortiz C","year":"2021","unstructured":"Ortiz C, Schierwagen R, Schaefer L, Klein S, Trepat X, Trebicka J. Extracellular matrix remodeling in chronic liver disease. Curr Tissue Microenviron Rep. 2021, 2:41-52. 10.1007\/s43152-021-00030-3","journal-title":"Curr Tissue Microenviron Rep"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0151736","article-title":"Extracellular matrix molecular remodeling in human liver fibrosis evolution","volume":"11","author":"Baiocchini A","year":"2016","unstructured":"Baiocchini A, Montaldo C, Conigliaro A, et al.. Extracellular matrix molecular remodeling in human liver fibrosis evolution. PLoS One. 2016, 11:e0151736. 10.1371\/journal.pone.0151736","journal-title":"PLoS One"},{"key":"ref72","article-title":"Kupffer cell metabolism and function","volume":"1","author":"Nguyen-Lefebvre AT","year":"2015","unstructured":"Nguyen-Lefebvre AT, Horuzsko A. Kupffer cell metabolism and function. J Enzymol Metab. 2015, 1:","journal-title":"J Enzymol Metab"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-1311-4_10","article-title":"Kupffer cells in health and disease","author":"Woltman AM","year":"2014","unstructured":"Woltman AM, Boonstra A, Naito M, Leenen PJ. Kupffer cells in health and disease. Macrophages: Biology and Role in the Pathology of Diseases. Biswas S, Mantovani A (ed): Springer, New York (NY); 2014. 217-47. 10.1007\/978-1-4939-1311-4_10"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.17219\/acem\/62759","article-title":"Kupffer cells in immune activation and tolerance toward HBV\/HCV infection","volume":"26","author":"Yuan F","year":"2017","unstructured":"Yuan F, Zhang W, Mu D, Gong J. Kupffer cells in immune activation and tolerance toward HBV\/HCV infection. Adv Clin Exp Med. 2017, 26:739-45. 10.17219\/acem\/62759","journal-title":"Adv Clin Exp Med"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.3390\/cells12172129","article-title":"Liver injury and regeneration: current understanding, new approaches, and future perspectives","volume":"12","author":"Hora S","year":"2023","unstructured":"Hora S, Wuestefeld T. Liver injury and regeneration: current understanding, new approaches, and future perspectives. Cells. 2023, 12:2129. 10.3390\/cells12172129","journal-title":"Cells"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1136\/flgastro-2013-100403","article-title":"Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging","volume":"5","author":"Dyson JK","year":"2014","unstructured":"Dyson JK, Anstee QM, McPherson S. Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging. Frontline Gastroenterol. 2014, 5:211-8. 10.1136\/flgastro-2013-100403","journal-title":"Frontline Gastroenterol"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-25857-z","article-title":"Correlation between ultrasound-diagnosed non-alcoholic fatty liver and periodontal condition in a cross-sectional study in Japan","volume":"8","author":"Iwasaki T","year":"2018","unstructured":"Iwasaki T, Hirose A, Azuma T, et al.. Correlation between ultrasound-diagnosed non-alcoholic fatty liver and periodontal condition in a cross-sectional study in Japan. Sci Rep. 2018, 8:7496. 10.1038\/s41598-018-25857-z","journal-title":"Sci Rep"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1177\/0300060518793039","article-title":"Clinical relevance of reporting fatty liver on ultrasound in asymptomatic patients during routine health checkups","volume":"46","author":"Mahale AR","year":"2018","unstructured":"Mahale AR, Prabhu SD, Nachiappan M, Fernandes M, Ullal S. Clinical relevance of reporting fatty liver on ultrasound in asymptomatic patients during routine health checkups. J Int Med Res. 2018, 46:4447-54. 10.1177\/0300060518793039","journal-title":"J Int Med Res"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/9047324","article-title":"Abdominal obesity as a predictive factor of nonalcoholic fatty liver disease assessed by ultrasonography and transient elastography in polycystic ovary syndrome and healthy women","volume":"2019","author":"Tantanavipas S","year":"2019","unstructured":"Tantanavipas S, Vallibhakara O, Sobhonslidsuk A, Phongkitkarun S, Vallibhakara SA, Promson K, Sophonsritsuk A. Abdominal obesity as a predictive factor of nonalcoholic fatty liver disease assessed by ultrasonography and transient elastography in polycystic ovary syndrome and healthy women. Biomed Res Int. 2019, 2019:9047324. 10.1155\/2019\/9047324","journal-title":"Biomed Res Int"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i42.15539","article-title":"Histopathology of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"20","author":"Takahashi Y","year":"2014","unstructured":"Takahashi Y, Fukusato T. Histopathology of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis. World J Gastroenterol. 2014, 20:15539-48. 10.3748\/wjg.v20.i42.15539","journal-title":"World J Gastroenterol"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2015.11.008","article-title":"Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"65","author":"Brown GT","year":"2016","unstructured":"Brown GT, Kleiner DE. Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Metabolism. 2016, 65:1080-6. 10.1016\/j.metabol.2015.11.008","journal-title":"Metabolism"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1111\/prd.12387","article-title":"Periodontal disease-related nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: an emerging concept of oral-liver axis","volume":"87","author":"Kuraji R","year":"2021","unstructured":"Kuraji R, Sekino S, Kapila Y, Numabe Y. Periodontal disease-related nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: an emerging concept of oral-liver axis. Periodontol 2000. 2021, 87:204-40. 10.1111\/prd.12387","journal-title":"Periodontol 2000"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12144759","article-title":"Associations between periodontal status and liver function in the Japanese population: a cross-sectional study","volume":"12","author":"Fujii T","year":"2023","unstructured":"Fujii T, Aoyama N, Kida S, Taniguchi K, Yata T, Minabe M, Komaki M. Associations between periodontal status and liver function in the Japanese population: a cross-sectional study. J Clin Med. 2023, 12:4759. 10.3390\/jcm12144759","journal-title":"J Clin Med"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1136\/postgradmedj-2018-136316","article-title":"Diagnosis and management of non-alcoholic fatty liver disease","volume":"95","author":"Jennison E","year":"2019","unstructured":"Jennison E, Patel J, Scorletti E, Byrne CD. Diagnosis and management of non-alcoholic fatty liver disease. Postgrad Med J. 2019, 95:314-22. 10.1136\/postgradmedj-2018-136316","journal-title":"Postgrad Med J"},{"key":"ref85","article-title":"What is the real function of the liver 'function' tests?","volume":"81","author":"Hall P","year":"2012","unstructured":"Hall P, Cash J. What is the real function of the liver 'function' tests?. Ulster Med J. 2012, 81:30-6.","journal-title":"Ulster Med J"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2016.517","article-title":"ACG clinical guideline: evaluation of abnormal liver chemistries","volume":"112","author":"Kwo PY","year":"2017","unstructured":"Kwo PY, Cohen SM, Lim JK. ACG clinical guideline: evaluation of abnormal liver chemistries. Am J Gastroenterol. 2017, 112:18-35. 10.1038\/ajg.2016.517","journal-title":"Am J Gastroenterol"},{"key":"ref87","doi-asserted-by":"crossref","DOI":"10.3390\/s6070756","article-title":"Aspartate aminotransferase (AST\/GOT) and alanine aminotransferase (ALT\/GPT) detection techniques","volume":"6","author":"Huang XJ","year":"2006","unstructured":"Huang XJ, Choi YK, Im HS, Yarimaga O, Yoon E, Kim HS. Aspartate aminotransferase (AST\/GOT) and alanine aminotransferase (ALT\/GPT) detection techniques. Sensors (Basel). 2006, 6:756-82.","journal-title":"Sensors (Basel)"},{"key":"ref88","article-title":"Alanine aminotransferase (ALT)","author":"Moriles KE","year":"2024","unstructured":"Moriles KE, Zubair M, Azer SA. Alanine aminotransferase (ALT). StatPearls Publishing, Treasure Island (FL); 2024."},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.7570\/jomes22021","article-title":"Recent epidemiology and risk factors of nonalcoholic fatty liver disease","volume":"31","author":"Huh Y","year":"2022","unstructured":"Huh Y, Cho YJ, Nam GE. Recent epidemiology and risk factors of nonalcoholic fatty liver disease. J Obes Metab Syndr. 2022, 31:17-27. 10.7570\/jomes22021","journal-title":"J Obes Metab Syndr"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2020.00071","article-title":"A description of risk factors for non-alcoholic fatty liver disease in the southern community cohort study: a nested case-control study","volume":"7","author":"Sarkar S","year":"2020","unstructured":"Sarkar S, Lipworth L, Kabagambe EK, et al.. A description of risk factors for non-alcoholic fatty liver disease in the southern community cohort study: a nested case-control study. Front Nutr. 2020, 7:71. 10.3389\/fnut.2020.00071","journal-title":"Front Nutr"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1016\/j.jds.2023.03.012","article-title":"The role of microbiome in the pathogenesis of oral-gut-liver axis between periodontitis and nonalcoholic fatty liver disease","volume":"18","author":"Chen TP","year":"2023","unstructured":"Chen TP, Yu HC, Lin WY, Chang YC. The role of microbiome in the pathogenesis of oral-gut-liver axis between periodontitis and nonalcoholic fatty liver disease. J Dent Sci. 2023, 18:972-5. 10.1016\/j.jds.2023.03.012","journal-title":"J Dent Sci"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1038\/nri3785","article-title":"Periodontitis: from microbial immune subversion to systemic inflammation","volume":"15","author":"Hajishengallis G","year":"2015","unstructured":"Hajishengallis G. Periodontitis: from microbial immune subversion to systemic inflammation. Nat Rev Immunol. 2015, 15:30-44. 10.1038\/nri3785","journal-title":"Nat Rev Immunol"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1186\/s43066-024-00340-9","article-title":"Oral microbiome dysbiosis and gastrointestinal diseases: a narrative review","volume":"14","author":"Elghannam MT","year":"2024","unstructured":"Elghannam MT, Hassanien MH, Ameen YA, et al.. Oral microbiome dysbiosis and gastrointestinal diseases: a narrative review. Egypt Liver J. 2024, 14:32. 10.1186\/s43066-024-00340-9","journal-title":"Egypt Liver J"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.3390\/nu14020352","article-title":"Gut microbiome and organ fibrosis","volume":"14","author":"Costa CF","year":"2022","unstructured":"Costa CF, Sampaio-Maia B, Araujo R, et al.. Gut microbiome and organ fibrosis. Nutrients. 2022, 14:352. 10.3390\/nu14020352","journal-title":"Nutrients"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1080\/20002297.2019.1586422","article-title":"Can oral bacteria affect the microbiome of the gut?","volume":"11","author":"Olsen I","year":"2019","unstructured":"Olsen I, Yamazaki K. Can oral bacteria affect the microbiome of the gut?. J Oral Microbiol. 2019, 11:1586422. 10.1080\/20002297.2019.1586422","journal-title":"J Oral Microbiol"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13213324","article-title":"Oral pathogenic bacteria and the oral-gut-liver axis: a new understanding of chronic liver diseases","volume":"13","author":"Lei Y","year":"2023","unstructured":"Lei Y, Li S, He M, Ao Z, Wang J, Wu Q, Wang Q. Oral pathogenic bacteria and the oral-gut-liver axis: a new understanding of chronic liver diseases. Diagnostics (Basel). 2023, 13:3324. 10.3390\/diagnostics13213324","journal-title":"Diagnostics (Basel)"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1186\/s41479-023-00106-8","article-title":"Innate immune responses in pneumonia","volume":"15","author":"Korkmaz FT","year":"2023","unstructured":"Korkmaz FT, Traber KE. Innate immune responses in pneumonia. Pneumonia (Nathan). 2023, 15:4. 10.1186\/s41479-023-00106-8","journal-title":"Pneumonia (Nathan)"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1712718","article-title":"Cytokines and chemokines in periodontitis","volume":"14","author":"Ramadan DE","year":"2020","unstructured":"Ramadan DE, Hariyani N, Indrawati R, Ridwan RD, Diyatri I. Cytokines and chemokines in periodontitis. Eur J Dent. 2020, 14:483-95. 10.1055\/s-0040-1712718","journal-title":"Eur J Dent"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.856118","article-title":"PAMPs and DAMPs as the bridge between periodontitis and atherosclerosis: the potential therapeutic targets","volume":"10","author":"Zhu X","year":"2022","unstructured":"Zhu X, Huang H, Zhao L. PAMPs and DAMPs as the bridge between periodontitis and atherosclerosis: the potential therapeutic targets. Front Cell Dev Biol. 2022, 10:856118. 10.3389\/fcell.2022.856118","journal-title":"Front Cell Dev Biol"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00361.2016","article-title":"Gut-liver axis at the frontier of host-microbial interactions","volume":"312","author":"Brandl K","year":"2017","unstructured":"Brandl K, Kumar V, Eckmann L. Gut-liver axis at the frontier of host-microbial interactions. Am J Physiol Gastrointest Liver Physiol. 2017, 312:G413-9. 10.1152\/ajpgi.00361.2016","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.1586\/17474124.2015.1057122","article-title":"Is intestinal inflammation linking dysbiosis to gut barrier dysfunction during liver disease?","volume":"9","author":"Brandl K","year":"2015","unstructured":"Brandl K, Schnabl B. Is intestinal inflammation linking dysbiosis to gut barrier dysfunction during liver disease?. Expert Rev Gastroenterol Hepatol. 2015, 9:1069-76. 10.1586\/17474124.2015.1057122","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.1038\/nature13568","article-title":"Alterations of the human gut microbiome in liver cirrhosis","volume":"513","author":"Qin N","year":"2014","unstructured":"Qin N, Yang F, Li A, et al.. Alterations of the human gut microbiome in liver cirrhosis. Nature. 2014, 513:59-64. 10.1038\/nature13568","journal-title":"Nature"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.3390\/nu15051269","article-title":"Involvement of periodontal disease in the pathogenesis and exacerbation of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis: a review","volume":"15","author":"Kobayashi T","year":"2023","unstructured":"Kobayashi T, Iwaki M, Nogami A, et al.. Involvement of periodontal disease in the pathogenesis and exacerbation of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis: a review. Nutrients. 2023, 15:1269. 10.3390\/nu15051269","journal-title":"Nutrients"},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.4082\/kjfm.20.0165","article-title":"Sedentary lifestyle: overview of updated evidence of potential health risks","volume":"41","author":"Park JH","year":"2020","unstructured":"Park JH, Moon JH, Kim HJ, Kong MH, Oh YH. Sedentary lifestyle: overview of updated evidence of potential health risks. Korean J Fam Med. 2020, 41:365-73. 10.4082\/kjfm.20.0165","journal-title":"Korean J Fam Med"},{"key":"ref105","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph20146433","article-title":"Environmental planning and non-communicable diseases: a systematic review on the role of the metabolomic profile","volume":"20","author":"Oliveira NC","year":"2023","unstructured":"Oliveira NC, Balikian J\u00fanior P, J\u00fanior AT, et al.. Environmental planning and non-communicable diseases: a systematic review on the role of the metabolomic profile. Int J Environ Res Public Health. 2023, 20:6433. 10.3390\/ijerph20146433","journal-title":"Int J Environ Res Public Health"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-023-15319-1","article-title":"The impact of high-risk lifestyle factors on all-cause mortality in the US non-communicable disease population","volume":"23","author":"Li Y","year":"2023","unstructured":"Li Y, Fan X, Wei L, Yang K, Jiao M. The impact of high-risk lifestyle factors on all-cause mortality in the US non-communicable disease population. BMC Public Health. 2023, 23:422. 10.1186\/s12889-023-15319-1","journal-title":"BMC Public Health"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2023.2255825","article-title":"Impact of Porphyromonas gingivalis-odontogenic infection on the pathogenesis of non-alcoholic fatty liver disease","volume":"55","author":"Liu L","year":"2023","unstructured":"Liu L, Geng Y, Xiong C. Impact of Porphyromonas gingivalis-odontogenic infection on the pathogenesis of non-alcoholic fatty liver disease. Ann Med. 2023, 55:10.1080\/07853890.2023.2255825","journal-title":"Ann Med"},{"key":"ref108","doi-asserted-by":"publisher","DOI":"10.1111\/prd.12427","article-title":"Periodontitis, chronic liver diseases, and the emerging oral-gut-liver axis","volume":"89","author":"Albuquerque-Souza E","year":"2022","unstructured":"Albuquerque-Souza E, Sahingur SE. Periodontitis, chronic liver diseases, and the emerging oral-gut-liver axis. Periodontol 2000. 2022, 89:125-41. 10.1111\/prd.12427","journal-title":"Periodontol 2000"},{"key":"ref109","doi-asserted-by":"publisher","DOI":"10.1111\/jre.13242","article-title":"Lipotoxicity: the missing link between diabetes and periodontitis?","volume":"59","author":"Sun Y","year":"2024","unstructured":"Sun Y, Yin Y, Yang S, et al.. Lipotoxicity: the missing link between diabetes and periodontitis?. J Periodontal Res. 2024, 59:431-45. 10.1111\/jre.13242","journal-title":"J Periodontal Res"},{"key":"ref110","doi-asserted-by":"publisher","DOI":"10.1177\/0022034519866442","article-title":"Oral diseases associated with nonalcoholic fatty liver disease in the United States","volume":"98","author":"Weintraub JA","year":"2019","unstructured":"Weintraub JA, Lopez Mitnik G, Dye BA. Oral diseases associated with nonalcoholic fatty liver disease in the United States. J Dent Res. 2019, 98:1219-26. 10.1177\/0022034519866442","journal-title":"J Dent Res"},{"key":"ref111","doi-asserted-by":"publisher","DOI":"10.1038\/nature12506","article-title":"Richness of human gut microbiome correlates with metabolic markers","volume":"500","author":"Le Chatelier E","year":"2013","unstructured":"Le Chatelier E, Nielsen T, Qin J, et al.. Richness of human gut microbiome correlates with metabolic markers. Nature. 2013, 500:541-6. 10.1038\/nature12506","journal-title":"Nature"},{"key":"ref112","doi-asserted-by":"publisher","DOI":"10.1111\/jcpe.13415","article-title":"Association between periodontitis and fibrotic progression of non-alcoholic fatty liver among Japanese adults","volume":"48","author":"Kuroe K","year":"2021","unstructured":"Kuroe K, Furuta M, Takeuchi K, et al.. Association between periodontitis and fibrotic progression of non-alcoholic fatty liver among Japanese adults. J Clin Periodontol. 2021, 48:368-77. 10.1111\/jcpe.13415","journal-title":"J Clin Periodontol"},{"key":"ref113","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2226922","article-title":"Targeting nonalcoholic fatty liver disease via gut microbiome-centered therapies","volume":"15","author":"Koning M","year":"2023","unstructured":"Koning M, Herrema H, Nieuwdorp M, Meijnikman AS. Targeting nonalcoholic fatty liver disease via gut microbiome-centered therapies. Gut Microbes. 2023, 15:2226922. 10.1080\/19490976.2023.2226922","journal-title":"Gut Microbes"},{"key":"ref114","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-019-03011-w","article-title":"The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD)","volume":"76","author":"Safari Z","year":"2019","unstructured":"Safari Z, G\u00e9rard P. The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD). Cell Mol Life Sci. 2019, 76:1541-58. 10.1007\/s00018-019-03011-w","journal-title":"Cell Mol Life Sci"},{"key":"ref115","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13985","article-title":"Periodontitis is associated with incident chronic liver disease-a population-based cohort study","volume":"39","author":"Helenius-Hietala J","year":"2019","unstructured":"Helenius-Hietala J, Suominen AL, Ruokonen H, et al.. Periodontitis is associated with incident chronic liver disease-a population-based cohort study. Liver Int. 2019, 39:583-91. 10.1111\/liv.13985","journal-title":"Liver Int"},{"key":"ref116","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/587279","article-title":"Mixed red-complex bacterial infection in periodontitis","volume":"2013","author":"Suzuki N","year":"2013","unstructured":"Suzuki N, Yoneda M, Hirofuji T. Mixed red-complex bacterial infection in periodontitis. Int J Dent. 2013, 2013:587279. 10.1155\/2013\/587279","journal-title":"Int J Dent"},{"key":"ref117","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_759_19","article-title":"Red complex: polymicrobial conglomerate in oral flora: a review","volume":"8","author":"Mohanty R","year":"2019","unstructured":"Mohanty R, Asopa SJ, Joseph MD, Singh B, Rajguru JP, Saidath K, Sharma U. Red complex: polymicrobial conglomerate in oral flora: a review. J Family Med Prim Care. 2019, 8:3480-6. 10.4103\/jfmpc.jfmpc_759_19","journal-title":"J Family Med Prim Care"},{"key":"ref118","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.00053","article-title":"Porphyromonas gingivalis: an overview of periodontopathic pathogen below the gum line","volume":"7","author":"How KY","year":"2016","unstructured":"How KY, Song KP, Chan KG. Porphyromonas gingivalis: an overview of periodontopathic pathogen below the gum line. Front Microbiol. 2016, 7:53. 10.3389\/fmicb.2016.00053","journal-title":"Front Microbiol"},{"key":"ref119","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.776996","article-title":"Porphyromonas gingivalis induces increases in branched-chain amino acid levels and exacerbates liver injury through livh\/livk","volume":"12","author":"Wu L","year":"2022","unstructured":"Wu L, Shi R, Bai H, Wang X, Wei J, Liu C, Wu Y. Porphyromonas gingivalis induces increases in branched-chain amino acid levels and exacerbates liver injury through livh\/livk. Front Cell Infect Microbiol. 2022, 12:776996. 10.3389\/fcimb.2022.776996","journal-title":"Front Cell Infect Microbiol"},{"key":"ref120","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-17917-2","article-title":"A cross-sectional study assessing the relationship between non-alcoholic fatty liver disease and periodontal disease","volume":"12","author":"Sato S","year":"2022","unstructured":"Sato S, Kamata Y, Kessoku T, et al.. A cross-sectional study assessing the relationship between non-alcoholic fatty liver disease and periodontal disease. Sci Rep. 2022, 12:13621. 10.1038\/s41598-022-17917-2","journal-title":"Sci Rep"},{"key":"ref121","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.04.044","article-title":"Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: a systematic review and meta-analysis","volume":"75","author":"Selvaraj EA","year":"2021","unstructured":"Selvaraj EA, M\u00f3zes FE, Jayaswal AN, et al.. Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: a systematic review and meta-analysis. J Hepatol. 2021, 75:770-85. 10.1016\/j.jhep.2021.04.044","journal-title":"J Hepatol"},{"key":"ref122","doi-asserted-by":"publisher","DOI":"10.1080\/20002297.2023.2205291","article-title":"Mechanisms of Porphyromonas gingivalis to translocate over the oral mucosa and other tissue barriers","volume":"15","author":"de Jongh CA","year":"2023","unstructured":"de Jongh CA, de Vries TJ, Bikker FJ, Gibbs S, Krom BP. Mechanisms of Porphyromonas gingivalis to translocate over the oral mucosa and other tissue barriers. J Oral Microbiol. 2023, 15:2205291. 10.1080\/20002297.2023.2205291","journal-title":"J Oral Microbiol"},{"key":"ref123","doi-asserted-by":"publisher","DOI":"10.3402\/jom.v7.29143","article-title":"Can oral infection be a risk factor for Alzheimer's disease?","volume":"7","author":"Olsen I","year":"2015","unstructured":"Olsen I, Singhrao SK. Can oral infection be a risk factor for Alzheimer's disease?. J Oral Microbiol. 2015, 7:29143. 10.3402\/jom.v7.29143","journal-title":"J Oral Microbiol"},{"key":"ref124","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdsr.2023.08.003","article-title":"Oral-gut axis as a novel biological mechanism linking periodontal disease and systemic diseases: a review","volume":"59","author":"Yamazaki K","year":"2023","unstructured":"Yamazaki K. Oral-gut axis as a novel biological mechanism linking periodontal disease and systemic diseases: a review. Jpn Dent Sci Rev. 2023, 59:273-80. 10.1016\/j.jdsr.2023.08.003","journal-title":"Jpn Dent Sci Rev"},{"key":"ref125","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-023-03374-w","article-title":"Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review","volume":"19","author":"Di Vincenzo F","year":"2024","unstructured":"Di Vincenzo F, Del Gaudio A, Petito V, Lopetuso LR, Scaldaferri F. Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review. Intern Emerg Med. 2024, 19:275-93. 10.1007\/s11739-023-03374-w","journal-title":"Intern Emerg Med"},{"key":"ref126","doi-asserted-by":"publisher","DOI":"10.3390\/nu16010092","article-title":"The role of gut microbiota and leaky gut in the pathogenesis of food allergy","volume":"16","author":"Poto R","year":"2023","unstructured":"Poto R, Fusco W, Rinninella E, et al.. The role of gut microbiota and leaky gut in the pathogenesis of food allergy. Nutrients. 2023, 16:92. 10.3390\/nu16010092","journal-title":"Nutrients"},{"key":"ref127","doi-asserted-by":"publisher","DOI":"10.1016\/j.micinf.2022.105040","article-title":"Porphyromonas gingivalis is a risk factor for the development of nonalcoholic fatty liver disease via ferroptosis","volume":"25","author":"Yao C","year":"2023","unstructured":"Yao C, Lan D, Li X, Wang Y, Qi S, Liu Y. Porphyromonas gingivalis is a risk factor for the development of nonalcoholic fatty liver disease via ferroptosis. Microbes Infect. 2023, 25:105040. 10.1016\/j.micinf.2022.105040","journal-title":"Microbes Infect"},{"key":"ref128","doi-asserted-by":"publisher","DOI":"10.20471\/acc.2021.60.03.22","article-title":"Association between periodontitis and liver disease","volume":"60","author":"Rin\u010di\u0107 G","year":"2022","unstructured":"Rin\u010di\u0107 G, Ga\u0107ina P, Virovi\u0107 Juki\u0107 L, Rin\u010di\u0107 N, Bo\u017ei\u0107 D, Badovinac A. Association between periodontitis and liver disease. Acta Clin Croat. 2022, 60:510-8. 10.20471\/acc.2021.60.03.22","journal-title":"Acta Clin Croat"},{"key":"ref129","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.709438","article-title":"Periodontal inflammation and systemic diseases: an overview","volume":"12","author":"Mart\u00ednez-Garc\u00eda M","year":"2021","unstructured":"Mart\u00ednez-Garc\u00eda M, Hern\u00e1ndez-Lemus E. Periodontal inflammation and systemic diseases: an overview. Front Physiol. 2021, 12:709438. 10.3389\/fphys.2021.709438","journal-title":"Front Physiol"},{"key":"ref130","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-023-06473-1","article-title":"Periodontitis is associated with insulin resistance in adults living with diabetes mellitus in Uganda: a cross- sectional study","volume":"16","author":"Kiryowa HM","year":"2023","unstructured":"Kiryowa HM, Munabi IG, Buwembo W, Rwenyonyi CM, Mwaka ES, Kaddumukasa M. Periodontitis is associated with insulin resistance in adults living with diabetes mellitus in Uganda: a cross- sectional study. BMC Res Notes. 2023, 16:217. 10.1186\/s13104-023-06473-1","journal-title":"BMC Res Notes"},{"key":"ref131","doi-asserted-by":"publisher","DOI":"10.1111\/prd.12433","article-title":"Periodontitis and cardiometabolic disorders: the role of lipopolysaccharide and endotoxemia","volume":"89","author":"Pussinen PJ","year":"2022","unstructured":"Pussinen PJ, Kopra E, Pieti\u00e4inen M, Lehto M, Zaric S, Paju S, Salminen A. Periodontitis and cardiometabolic disorders: the role of lipopolysaccharide and endotoxemia. Periodontol 2000. 2022, 89:19-40. 10.1111\/prd.12433","journal-title":"Periodontol 2000"},{"key":"ref132","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11050914","article-title":"The inhibition of LPS-induced oxidative stress and inflammatory responses is associated with the protective effect of (-)-epigallocatechin-3-gallate on bovine hepatocytes and murine liver","volume":"11","author":"Xu T","year":"2022","unstructured":"Xu T, Liu R, Zhu H, Zhou Y, Pei T, Yang Z. The inhibition of LPS-induced oxidative stress and inflammatory responses is associated with the protective effect of (-)-epigallocatechin-3-gallate on bovine hepatocytes and murine liver. Antioxidants (Basel). 2022, 11:914. 10.3390\/antiox11050914","journal-title":"Antioxidants (Basel)"},{"key":"ref133","doi-asserted-by":"publisher","DOI":"10.3390\/cells11244038","article-title":"Role of endogenous lipopolysaccharides in neurological disorders","volume":"11","author":"Kalyan M","year":"2022","unstructured":"Kalyan M, Tousif AH, Sonali S, et al.. Role of endogenous lipopolysaccharides in neurological disorders. Cells. 2022, 11:4038. 10.3390\/cells11244038","journal-title":"Cells"},{"key":"ref134","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.09.051","article-title":"CD14 controls the LPS-induced endocytosis of Toll-like receptor 4","volume":"147","author":"Zanoni I","year":"2011","unstructured":"Zanoni I, Ostuni R, Marek LR, et al.. CD14 controls the LPS-induced endocytosis of Toll-like receptor 4. Cell. 2011, 147:868-80. 10.1016\/j.cell.2011.09.051","journal-title":"Cell"},{"key":"ref135","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-12-16","article-title":"Involvement of a periodontal pathogen, Porphyromonas gingivalis on the pathogenesis of non-alcoholic fatty liver disease","volume":"12","author":"Yoneda M","year":"2012","unstructured":"Yoneda M, Naka S, Nakano K, et al.. Involvement of a periodontal pathogen, Porphyromonas gingivalis on the pathogenesis of non-alcoholic fatty liver disease. BMC Gastroenterol. 2012, 12:16. 10.1186\/1471-230X-12-16","journal-title":"BMC Gastroenterol"},{"key":"ref136","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-017-1368-4","article-title":"Involvement of Porphyromonas gingivalis in the progression of non-alcoholic fatty liver disease","volume":"53","author":"Nakahara T","year":"2018","unstructured":"Nakahara T, Hyogo H, Ono A, et al.. Involvement of Porphyromonas gingivalis in the progression of non-alcoholic fatty liver disease. J Gastroenterol. 2018, 53:269-80. 10.1007\/s00535-017-1368-4","journal-title":"J Gastroenterol"},{"key":"ref137","doi-asserted-by":"publisher","DOI":"10.1902\/jop.1996.67.10s.1085","article-title":"Severe periodontitis and risk for poor glycemic control in patients with non-insulin-dependent diabetes mellitus","volume":"67","author":"Taylor GW","year":"1996","unstructured":"Taylor GW, Burt BA, Becker MP, Genco RJ, Shlossman M, Knowler WC, Pettitt DJ. Severe periodontitis and risk for poor glycemic control in patients with non-insulin-dependent diabetes mellitus. J Periodontol. 1996, 67:1085-93. 10.1902\/jop.1996.67.10s.1085","journal-title":"J Periodontol"},{"key":"ref138","doi-asserted-by":"publisher","DOI":"10.14309\/ctg.0000000000000520","article-title":"Periodontal treatment and usual care for nonalcoholic fatty liver disease: a multicenter, randomized controlled trial","volume":"13","author":"Kamata Y","year":"2022","unstructured":"Kamata Y, Kessoku T, Shimizu T, et al.. Periodontal treatment and usual care for nonalcoholic fatty liver disease: a multicenter, randomized controlled trial. Clin Transl Gastroenterol. 2022, 13:e00520. 10.14309\/ctg.0000000000000520","journal-title":"Clin Transl Gastroenterol"},{"key":"ref139","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22073728","article-title":"Relationship between NAFLD and periodontal disease from the view of clinical and basic research, and immunological response","volume":"22","author":"Hatasa M","year":"2021","unstructured":"Hatasa M, Yoshida S, Takahashi H, et al.. Relationship between NAFLD and periodontal disease from the view of clinical and basic research, and immunological response. Int J Mol Sci. 2021, 22:3728. 10.3390\/ijms22073728","journal-title":"Int J Mol Sci"},{"key":"ref140","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2014\/9845.4766","article-title":"Aggregatibacter actinomycetemcomitans-a tooth killer?","volume":"8","author":"Raja M","year":"2014","unstructured":"Raja M, Ummer F, Dhivakar CP. Aggregatibacter actinomycetemcomitans-a tooth killer?. J Clin Diagn Res. 2014, 8:ZE13-6. 10.7860\/JCDR\/2014\/9845.4766","journal-title":"J Clin Diagn Res"},{"key":"ref141","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-14260-9","article-title":"Periodontal pathogenic bacteria, Aggregatibacter actinomycetemcomitans affect non-alcoholic fatty liver disease by altering gut microbiota and glucose metabolism","volume":"7","author":"Komazaki R","year":"2017","unstructured":"Komazaki R, Katagiri S, Takahashi H, et al.. Periodontal pathogenic bacteria, Aggregatibacter actinomycetemcomitans affect non-alcoholic fatty liver disease by altering gut microbiota and glucose metabolism. Sci Rep. 2017, 7:13950. 10.1038\/s41598-017-14260-9","journal-title":"Sci Rep"},{"key":"ref142","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.822190","article-title":"Oral and gut microbial dysbiosis and non-alcoholic fatty liver disease: the central role of Porphyromonas gingivalis","volume":"9","author":"Wang T","year":"2022","unstructured":"Wang T, Ishikawa T, Sasaki M, Chiba T. Oral and gut microbial dysbiosis and non-alcoholic fatty liver disease: the central role of Porphyromonas gingivalis. Front Med (Lausanne). 2022, 9:822190. 10.3389\/fmed.2022.822190","journal-title":"Front Med (Lausanne)"},{"key":"ref143","doi-asserted-by":"publisher","DOI":"10.3389\/froh.2022.981343","article-title":"Aggregatibacter actinomycetemcomitans and Filifactor alocis: two exotoxin-producing oral pathogens","volume":"3","author":"Ozuna H","year":"2022","unstructured":"Ozuna H, Snider I, Belibasakis GN, Oscarsson J, Johansson A, Uriarte SM. Aggregatibacter actinomycetemcomitans and Filifactor alocis: two exotoxin-producing oral pathogens. Front Oral Health. 2022, 3:981343. 10.3389\/froh.2022.981343","journal-title":"Front Oral Health"},{"key":"ref144","doi-asserted-by":"publisher","DOI":"10.4161\/21505594.2014.982428","article-title":"Aggregatibacter actinomycetemcomitans: virulence of its leukotoxin and association with aggressive periodontitis","volume":"6","author":"\u00c5berg CH","year":"2015","unstructured":"\u00c5berg CH, Kelk P, Johansson A. Aggregatibacter actinomycetemcomitans: virulence of its leukotoxin and association with aggressive periodontitis. Virulence. 2015, 6:188-95. 10.4161\/21505594.2014.982428","journal-title":"Virulence"},{"key":"ref145","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.24157","article-title":"Aggregatibacter actinomycetemcomitans lipopolysaccharide regulates bone sialoprotein gene transcription","volume":"113","author":"Li X","year":"2012","unstructured":"Li X, Zhou L, Takai H, et al.. Aggregatibacter actinomycetemcomitans lipopolysaccharide regulates bone sialoprotein gene transcription. J Cell Biochem. 2012, 113:2822-34. 10.1002\/jcb.24157","journal-title":"J Cell Biochem"},{"key":"ref146","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.105905","article-title":"Diet-induced gut dysbiosis and inflammation: key drivers of obesity-driven NASH","volume":"26","author":"Kang GG","year":"2023","unstructured":"Kang GG, Trevaskis NL, Murphy AJ, Febbraio MA. Diet-induced gut dysbiosis and inflammation: key drivers of obesity-driven NASH. iScience. 2023, 26:105905. 10.1016\/j.isci.2022.105905","journal-title":"iScience"},{"key":"ref147","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222413177","article-title":"The link between gut dysbiosis caused by a high-fat diet and hearing loss","volume":"22","author":"Kociszewska D","year":"2021","unstructured":"Kociszewska D, Chan J, Thorne PR, Vlajkovic SM. The link between gut dysbiosis caused by a high-fat diet and hearing loss. Int J Mol Sci. 2021, 22:13177. 10.3390\/ijms222413177","journal-title":"Int J Mol Sci"},{"key":"ref148","doi-asserted-by":"publisher","DOI":"10.1128\/genomeA.00114-16","article-title":"Complete genome sequence of Turicibacter sp. strain H121, isolated from the feces of a contaminated germ-free mouse","volume":"4","author":"Auchtung TA","year":"2016","unstructured":"Auchtung TA, Holder ME, Gesell JR, et al.. Complete genome sequence of Turicibacter sp. strain H121, isolated from the feces of a contaminated germ-free mouse. Genome Announc. 2016, 4:e00114-16. 10.1128\/genomeA.00114-16","journal-title":"Genome Announc"},{"key":"ref149","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39403-7","article-title":"Gut microbiota Turicibacter strains differentially modify bile acids and host lipids","volume":"14","author":"Lynch JB","year":"2023","unstructured":"Lynch JB, Gonzalez EL, Choy K, et al.. Gut microbiota Turicibacter strains differentially modify bile acids and host lipids. Nat Commun. 2023, 14:3669. 10.1038\/s41467-023-39403-7","journal-title":"Nat Commun"},{"key":"ref150","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-019-0227-6","article-title":"Building community in the gut: a role for mucosal serotonin","volume":"17","author":"Hoffman JM","year":"2020","unstructured":"Hoffman JM, Margolis KG. Building community in the gut: a role for mucosal serotonin. Nat Rev Gastroenterol Hepatol. 2020, 17:6-8. 10.1038\/s41575-019-0227-6","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref151","doi-asserted-by":"publisher","DOI":"10.1159\/000481401","article-title":"Gut microbiome in inflammatory bowel disease and other chronic immune-mediated inflammatory diseases","volume":"2","author":"Bernstein CN","year":"2017","unstructured":"Bernstein CN, Forbes JD. Gut microbiome in inflammatory bowel disease and other chronic immune-mediated inflammatory diseases. Inflamm Intest Dis. 2017, 2:116-23. 10.1159\/000481401","journal-title":"Inflamm Intest Dis"},{"key":"ref152","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41536-8","article-title":"Bridging of host-microbiota tryptophan partitioning by the serotonin pathway in fungal pneumonia","volume":"14","author":"Renga G","year":"2023","unstructured":"Renga G, D'Onofrio F, Pariano M, et al.. Bridging of host-microbiota tryptophan partitioning by the serotonin pathway in fungal pneumonia. Nat Commun. 2023, 14:5753. 10.1038\/s41467-023-41536-8","journal-title":"Nat Commun"},{"key":"ref153","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1203087","article-title":"Turicibacter fermentation enhances the inhibitory effects of Antrodia camphorata supplementation on tumorigenic serotonin and Wnt pathways and promotes ROS-mediated apoptosis of Caco-2 cells","volume":"14","author":"Lin TC","year":"2023","unstructured":"Lin TC, Soorneedi A, Guan Y, Tang Y, Shi E, Moore MD, Liu Z. Turicibacter fermentation enhances the inhibitory effects of Antrodia camphorata supplementation on tumorigenic serotonin and Wnt pathways and promotes ROS-mediated apoptosis of Caco-2 cells. Front Pharmacol. 2023, 14:1203087. 10.3389\/fphar.2023.1203087","journal-title":"Front Pharmacol"},{"key":"ref154","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2018.12.018","article-title":"The short chain fatty acid butyrate imprints an antimicrobial program in macrophages","volume":"50","author":"Schulthess J","year":"2019","unstructured":"Schulthess J, Pandey S, Capitani M, et al.. The short chain fatty acid butyrate imprints an antimicrobial program in macrophages. Immunity. 2019, 50:432-45.e7. 10.1016\/j.immuni.2018.12.018","journal-title":"Immunity"},{"key":"ref155","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2023.06.007","article-title":"The role of gut microbiome-derived short-chain fatty acid butyrate in hepatobiliary diseases","volume":"193","author":"Pant K","year":"2023","unstructured":"Pant K, Venugopal SK, Lorenzo Pisarello MJ, Gradilone SA. The role of gut microbiome-derived short-chain fatty acid butyrate in hepatobiliary diseases. Am J Pathol. 2023, 193:1455-67. 10.1016\/j.ajpath.2023.06.007","journal-title":"Am J Pathol"},{"key":"ref156","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1098881","article-title":"Butyrate and obesity: current research status and future prospect","volume":"14","author":"Peng K","year":"2023","unstructured":"Peng K, Dong W, Luo T, Tang H, Zhu W, Huang Y, Yang X. Butyrate and obesity: current research status and future prospect. Front Endocrinol (Lausanne). 2023, 14:1098881. 10.3389\/fendo.2023.1098881","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref157","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13498","article-title":"Butyrate to combat obesity and obesity-associated metabolic disorders: current status and future implications for therapeutic use","volume":"23","author":"van Deuren T","year":"2022","unstructured":"van Deuren T, Blaak EE, Canfora EE. Butyrate to combat obesity and obesity-associated metabolic disorders: current status and future implications for therapeutic use. Obes Rev. 2022, 23:e13498. 10.1111\/obr.13498","journal-title":"Obes Rev"},{"key":"ref158","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.693479","article-title":"Multifaceted impacts of periodontal pathogens in disorders of the intestinal barrier","volume":"12","author":"Liu Y","year":"2021","unstructured":"Liu Y, Huang W, Wang J, et al.. Multifaceted impacts of periodontal pathogens in disorders of the intestinal barrier. Front Immunol. 2021, 12:693479. 10.3389\/fimmu.2021.693479","journal-title":"Front Immunol"},{"key":"ref159","doi-asserted-by":"publisher","DOI":"10.1080\/20002297.2023.2213112","article-title":"The interplay between oral microbiota, gut microbiota and systematic diseases","volume":"15","author":"Tan X","year":"2023","unstructured":"Tan X, Wang Y, Gong T. The interplay between oral microbiota, gut microbiota and systematic diseases. J Oral Microbiol. 2023, 15:2213112. 10.1080\/20002297.2023.2213112","journal-title":"J Oral Microbiol"},{"key":"ref160","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-024-00966-0","article-title":"The individual response to antibiotics and diet-insights into gut microbial resilience and host metabolism","volume":"20","author":"Vliex LM","year":"2024","unstructured":"Vliex LM, Penders J, Nauta A, Zoetendal EG, Blaak EE. The individual response to antibiotics and diet-insights into gut microbial resilience and host metabolism. Nat Rev Endocrinol. 2024, 20:387-98. 10.1038\/s41574-024-00966-0","journal-title":"Nat Rev Endocrinol"},{"key":"ref161","doi-asserted-by":"publisher","DOI":"10.1096\/fj.14-265983","article-title":"Alteration of gut microbiota by vancomycin and bacitracin improves insulin resistance via glucagon-like peptide 1 in diet-induced obesity","volume":"29","author":"Hwang I","year":"2015","unstructured":"Hwang I, Park YJ, Kim YR, et al.. Alteration of gut microbiota by vancomycin and bacitracin improves insulin resistance via glucagon-like peptide 1 in diet-induced obesity. FASEB J. 2015, 29:2397-411. 10.1096\/fj.14-265983","journal-title":"FASEB J"},{"key":"ref162","doi-asserted-by":"publisher","DOI":"10.3402\/jom.v5i0.20320","article-title":"Antibiotic susceptibility of Aggregatibacter actinomycetemcomitans JP2 in a biofilm","volume":"5","author":"Oettinger-Barak O","year":"2013","unstructured":"Oettinger-Barak O, Dashper SG, Catmull DV, Adams GG, Sela MN, Machtei EE, Reynolds EC. Antibiotic susceptibility of Aggregatibacter actinomycetemcomitans JP2 in a biofilm. J Oral Microbiol. 2013, 5:20320. 10.3402\/jom.v5i0.20320","journal-title":"J Oral Microbiol"},{"key":"ref163","doi-asserted-by":"publisher","DOI":"10.4103\/jomfp.JOMFP_123_19","article-title":"Antimicrobial susceptibility pattern of oral isolates of Aggregatibacter actinomycetemcomitans","volume":"23","author":"Bhat KG","year":"2019","unstructured":"Bhat KG, Khot P, Patil S, Pattar G, Majukar S. Antimicrobial susceptibility pattern of oral isolates of Aggregatibacter actinomycetemcomitans. J Oral Maxillofac Pathol. 2019, 23:231-5. 10.4103\/jomfp.JOMFP_123_19","journal-title":"J Oral Maxillofac Pathol"},{"key":"ref164","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.706432","article-title":"Serum C-reactive protein and periodontitis: a systematic review and meta-analysis","volume":"12","author":"Machado V","year":"2021","unstructured":"Machado V, Botelho J, Escalda C, et al.. Serum C-reactive protein and periodontitis: a systematic review and meta-analysis. Front Immunol. 2021, 12:706432. 10.3389\/fimmu.2021.706432","journal-title":"Front Immunol"},{"key":"ref165","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13221","article-title":"Gamma-glutamyltransferase-friend or foe within?","volume":"36","author":"Kunutsor SK","year":"2016","unstructured":"Kunutsor SK. Gamma-glutamyltransferase-friend or foe within?. Liver Int. 2016, 36:1723-34. 10.1111\/liv.13221","journal-title":"Liver Int"},{"key":"ref166","article-title":"Correlation between gamma-glutamyl transferase activity and glutathione levels in molecular subgroups of breast cancer","volume":"16","author":"Akayd\u0131n SY","year":"2020","unstructured":"Akayd\u0131n SY, Saliho\u011flu EM, G\u00fcng\u00f6r DG, Karanl\u0131k H, Demokan S. Correlation between gamma-glutamyl transferase activity and glutathione levels in molecular subgroups of breast cancer. Eur J Breast Health. 2020, 16:72-6.","journal-title":"Eur J Breast Health"},{"key":"ref167","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0088532","article-title":"Gamma-glutamyltransferase fractions in human plasma and bile: characteristic and biogenesis","volume":"9","author":"Fornaciari I","year":"2014","unstructured":"Fornaciari I, Fierabracci V, Corti A, et al.. Gamma-glutamyltransferase fractions in human plasma and bile: characteristic and biogenesis. PLoS One. 2014, 9:e88532. 10.1371\/journal.pone.0088532","journal-title":"PLoS One"},{"key":"ref168","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000028443","article-title":"Characteristics of peripheral blood gamma-glutamyl transferase in different liver diseases","volume":"101","author":"Xing M","year":"2022","unstructured":"Xing M, Gao M, Li J, Han P, Mei L, Zhao L. Characteristics of peripheral blood gamma-glutamyl transferase in different liver diseases. Medicine (Baltimore). 2022, 101:e28443. 10.1097\/MD.0000000000028443","journal-title":"Medicine (Baltimore)"},{"key":"ref169","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-420117-0.00003-7","article-title":"Gamma-glutamyl transpeptidase: redox regulation and drug resistance","volume":"122","author":"Hanigan MH","year":"2014","unstructured":"Hanigan MH. Gamma-glutamyl transpeptidase: redox regulation and drug resistance. Adv Cancer Res. 2014, 122:103-41. 10.1016\/B978-0-12-420117-0.00003-7","journal-title":"Adv Cancer Res"},{"key":"ref170","article-title":"Glutathione!","volume":"13","author":"Pizzorno J","year":"2014","unstructured":"Pizzorno J. Glutathione!. Integr Med (Encinitas). 2014, 13:8-12.","journal-title":"Integr Med (Encinitas)"},{"key":"ref171","doi-asserted-by":"publisher","DOI":"10.1080\/20014091084227","article-title":"Gamma glutamyl transferase","volume":"38","author":"Whitfield JB","year":"2001","unstructured":"Whitfield JB. Gamma glutamyl transferase. Crit Rev Clin Lab Sci. 2001, 38:263-355. 10.1080\/20014091084227","journal-title":"Crit Rev Clin Lab Sci"},{"key":"ref172","article-title":"Role of gamma-glutamyltransferase in cardiovascular diseases","volume":"18","author":"Jiang S","year":"2013","unstructured":"Jiang S, Jiang D, Tao Y. Role of gamma-glutamyltransferase in cardiovascular diseases. Exp Clin Cardiol. 2013, 18:53-6.","journal-title":"Exp Clin Cardiol"},{"key":"ref173","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12121966","article-title":"Potential association of isolated \u03b3-glutamyltransferase elevation with incident ischemic heart disease in lean Koreans","volume":"12","author":"Sung Y","year":"2022","unstructured":"Sung Y, Lee YJ, Jung DH, Park B. Potential association of isolated \u03b3-glutamyltransferase elevation with incident ischemic heart disease in lean Koreans. J Pers Med. 2022, 12:1966. 10.3390\/jpm12121966","journal-title":"J Pers Med"},{"key":"ref174","doi-asserted-by":"crossref","DOI":"10.1001\/archinte.1982.00340140081015","article-title":"Gamma-glutamyl transpeptidase levels in thyroid disease","volume":"142","author":"Azizi F","year":"1982","unstructured":"Azizi F. Gamma-glutamyl transpeptidase levels in thyroid disease. Arch Intern Med. 1982, 142:79-81.","journal-title":"Arch Intern Med"},{"key":"ref175","doi-asserted-by":"publisher","DOI":"10.1177\/11795514221074672","article-title":"Hyperthyroidism and liver dysfunction: a review of a common comorbidity","volume":"15","author":"Yorke E","year":"2022","unstructured":"Yorke E. Hyperthyroidism and liver dysfunction: a review of a common comorbidity. Clin Med Insights Endocrinol Diabetes. 2022, 15:10.1177\/11795514221074672","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"key":"ref176","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2013.09.016","article-title":"The association of alcohol intake with \u03b3-glutamyl transferase (GGT) levels: evidence for correlated genetic effects","volume":"134","author":"van Beek JH","year":"2014","unstructured":"van Beek JH, de Moor MH, Geels LM, et al.. The association of alcohol intake with \u03b3-glutamyl transferase (GGT) levels: evidence for correlated genetic effects. Drug Alcohol Depend. 2014, 134:99-105. 10.1016\/j.drugalcdep.2013.09.016","journal-title":"Drug Alcohol Depend"},{"key":"ref177","doi-asserted-by":"publisher","DOI":"10.21037\/atm-19-4516","article-title":"Association between ratio of \u03b3-glutamyl transpeptidase to high-density lipoprotein cholesterol and prevalence of nonalcoholic fatty liver disease and metabolic syndrome: a cross-sectional study","volume":"8","author":"Feng G","year":"2020","unstructured":"Feng G, Feng L, Zhao Y. Association between ratio of \u03b3-glutamyl transpeptidase to high-density lipoprotein cholesterol and prevalence of nonalcoholic fatty liver disease and metabolic syndrome: a cross-sectional study. Ann Transl Med. 2020, 8:634. 10.21037\/atm-19-4516","journal-title":"Ann Transl Med"},{"key":"ref178","doi-asserted-by":"publisher","DOI":"10.1016\/j.archoralbio.2008.02.002","article-title":"Protein carbonyl levels in serum and gingival crevicular fluid in patients with chronic periodontitis","volume":"53","author":"Baltacio\u011flu E","year":"2008","unstructured":"Baltacio\u011flu E, Akalin FA, Alver A, De\u011fer O, Karabulut E. Protein carbonyl levels in serum and gingival crevicular fluid in patients with chronic periodontitis. Arch Oral Biol. 2008, 53:716-22. 10.1016\/j.archoralbio.2008.02.002","journal-title":"Arch Oral Biol"},{"key":"ref179","doi-asserted-by":"publisher","DOI":"10.1016\/j.jobcr.2022.03.002","article-title":"Assessment of gingival crevicular fluid levels of gamma glutamyl transferase in chronic periodontitis patients before and after non-surgical periodontal therapy: a clinico-biochemical study","volume":"12","author":"G K","year":"2022","unstructured":"G K, Shankar SM, Nagesh U, Gururaj SB, Chidambar CK, Bhushan K. Assessment of gingival crevicular fluid levels of gamma glutamyl transferase in chronic periodontitis patients before and after non-surgical periodontal therapy: a clinico-biochemical study. J Oral Biol Craniofac Res. 2022, 12:481-5. 10.1016\/j.jobcr.2022.03.002","journal-title":"J Oral Biol Craniofac Res"},{"key":"ref180","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.891204","article-title":"Serum \u03b3-glutamyltransferase level is associated with periodontal disease independent of drinking habits in Japanese adults","volume":"20","author":"Morita T","year":"2014","unstructured":"Morita T, Yamazaki Y, Fujiharu C, et al.. Serum \u03b3-glutamyltransferase level is associated with periodontal disease independent of drinking habits in Japanese adults. Med Sci Monit. 2014, 20:2109-16. 10.12659\/MSM.891204","journal-title":"Med Sci Monit"},{"key":"ref181","doi-asserted-by":"publisher","DOI":"10.1111\/jcpe.13216","article-title":"Association between periodontal inflammation and hypertension using periodontal inflamed surface area and bleeding on probing","volume":"47","author":"Pietropaoli D","year":"2020","unstructured":"Pietropaoli D, Del Pinto R, Ferri C, Marzo G, Giannoni M, Ortu E, Monaco A. Association between periodontal inflammation and hypertension using periodontal inflamed surface area and bleeding on probing. J Clin Periodontol. 2020, 47:160-72. 10.1111\/jcpe.13216","journal-title":"J Clin Periodontol"},{"key":"ref182","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-051X.2009.01377.x","article-title":"Dose-response relationship between periodontal inflamed surface area and HbA1c in type 2 diabetics","volume":"36","author":"Nesse W","year":"2009","unstructured":"Nesse W, Linde A, Abbas F, et al.. Dose-response relationship between periodontal inflamed surface area and HbA1c in type 2 diabetics. J Clin Periodontol. 2009, 36:295-300. 10.1111\/j.1600-051X.2009.01377.x","journal-title":"J Clin Periodontol"},{"key":"ref183","doi-asserted-by":"publisher","DOI":"10.3390\/dj10020016","article-title":"Oral health and liver disease: bidirectional associations-a narrative review","volume":"10","author":"\u00c5berg F","year":"2022","unstructured":"\u00c5berg F, Helenius-Hietala J. Oral health and liver disease: bidirectional associations-a narrative review. Dent J (Basel). 2022, 10:16. 10.3390\/dj10020016","journal-title":"Dent J (Basel)"},{"key":"ref184","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-020-4201-y","article-title":"Efficacy and safety of PERIOdontal treatment versus usual care for Nonalcoholic liver disease: protocol of the PERION multicenter, two-arm, open-label, randomized trial","volume":"21","author":"Kamata Y","year":"2020","unstructured":"Kamata Y, Kessoku T, Shimizu T, et al.. Efficacy and safety of PERIOdontal treatment versus usual care for Nonalcoholic liver disease: protocol of the PERION multicenter, two-arm, open-label, randomized trial. Trials. 2020, 21:291. 10.1186\/s13063-020-4201-y","journal-title":"Trials"},{"key":"ref185","doi-asserted-by":"publisher","DOI":"10.1002\/JPER.20-0839","article-title":"A re-evaluation of scaling and root planing","volume":"92","author":"Cobb CM","year":"2021","unstructured":"Cobb CM, Sottosanti JS. A re-evaluation of scaling and root planing. J Periodontol. 2021, 92:1370-8. 10.1002\/JPER.20-0839","journal-title":"J Periodontol"},{"key":"ref186","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(20)30216-8","article-title":"Lubiprostone in patients with non-alcoholic fatty liver disease: a randomized, double-blind, placebo-controlled, phase 2a trial","volume":"5","author":"Kessoku T","year":"2020","unstructured":"Kessoku T, Imajo K, Kobayashi T, et al.. Lubiprostone in patients with non-alcoholic fatty liver disease: a randomized, double-blind, placebo-controlled, phase 2a trial. Lancet Gastroenterol Hepatol. 2020, 5:996-1007. 10.1016\/S2468-1253(20)30216-8","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref187","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2018.04.002","article-title":"Efficacy, safety, and tolerability of lubiprostone for the treatment of non-alcoholic fatty liver disease in adult patients with constipation: the LUBIPRONE, double-blind, randomised, placebo-controlled study design","volume":"69","author":"Kessoku T","year":"2018","unstructured":"Kessoku T, Imajo K, Kobayashi T, et al.. Efficacy, safety, and tolerability of lubiprostone for the treatment of non-alcoholic fatty liver disease in adult patients with constipation: the LUBIPRONE, double-blind, randomised, placebo-controlled study design. Contemp Clin Trials. 2018, 69:40-7. 10.1016\/j.cct.2018.04.002","journal-title":"Contemp Clin Trials"},{"key":"ref188","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15030811","article-title":"The ClC-2 chloride channel activator, lubiprostone, improves intestinal barrier function in biopsies from Crohn's disease but not ulcerative colitis patients","volume":"15","author":"Park YS","year":"2023","unstructured":"Park YS, Kang SB, Marchelletta RR, et al.. The ClC-2 chloride channel activator, lubiprostone, improves intestinal barrier function in biopsies from Crohn's disease but not ulcerative colitis patients. Pharmaceutics. 2023, 15:811. 10.3390\/pharmaceutics15030811","journal-title":"Pharmaceutics"},{"key":"ref189","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.1861-23","article-title":"Prevalence of non-alcoholic fatty liver disease detected by computed tomography in the general population compared with ultrasonography","volume":"63","author":"Ito Y","year":"2024","unstructured":"Ito Y, Yoshioka K, Hayashi K, et al.. Prevalence of non-alcoholic fatty liver disease detected by computed tomography in the general population compared with ultrasonography. Intern Med. 2024, 63:159-67. 10.2169\/internalmedicine.1861-23","journal-title":"Intern Med"},{"key":"ref190","doi-asserted-by":"publisher","DOI":"10.2334\/josnusd.57.335","article-title":"Association of periodontal status with liver abnormalities and metabolic syndrome","volume":"57","author":"Ahmad A","year":"2015","unstructured":"Ahmad A, Furuta M, Shinagawa T, Takeuchi K, Takeshita T, Shimazaki Y, Yamashita Y. Association of periodontal status with liver abnormalities and metabolic syndrome. J Oral Sci. 2015, 57:335-43. 10.2334\/josnusd.57.335","journal-title":"J Oral Sci"},{"key":"ref191","doi-asserted-by":"publisher","DOI":"10.1136\/jim-2021-001831","article-title":"Effects of non-surgical treatment of chronic periodontitis on insulin resistance and glucose tolerance in subjects without diabetes (PARODIA 2 study)","volume":"69","author":"Nana Nana AR","year":"2021","unstructured":"Nana Nana AR, Tsobgny Tsague NF, Lontchi-Yimagou E, et al.. Effects of non-surgical treatment of chronic periodontitis on insulin resistance and glucose tolerance in subjects without diabetes (PARODIA 2 study). J Investig Med. 2021, 69:1377-81. 10.1136\/jim-2021-001831","journal-title":"J Investig Med"},{"key":"ref192","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.50.5166","article-title":"Inflammatory cytokines, adiponectin, insulin resistance and metabolic control after periodontal intervention in patients with type 2 diabetes and chronic periodontitis","volume":"50","author":"Sun WL","year":"2011","unstructured":"Sun WL, Chen LL, Zhang SZ, Wu YM, Ren YZ, Qin GM. Inflammatory cytokines, adiponectin, insulin resistance and metabolic control after periodontal intervention in patients with type 2 diabetes and chronic periodontitis. Intern Med. 2011, 50:1569-74. 10.2169\/internalmedicine.50.5166","journal-title":"Intern Med"},{"key":"ref193","doi-asserted-by":"publisher","DOI":"10.5051\/jpis.2014.44.4.158","article-title":"Impact of scaling and root planing on C-reactive protein levels in gingival crevicular fluid and serum in chronic periodontitis patients with or without diabetes mellitus","volume":"44","author":"Mohan M","year":"2014","unstructured":"Mohan M, Jhingran R, Bains VK, Gupta V, Madan R, Rizvi I, Mani K. Impact of scaling and root planing on C-reactive protein levels in gingival crevicular fluid and serum in chronic periodontitis patients with or without diabetes mellitus. J Periodontal Implant Sci. 2014, 44:158-68. 10.5051\/jpis.2014.44.4.158","journal-title":"J Periodontal Implant Sci"},{"key":"ref194","doi-asserted-by":"crossref","DOI":"10.1186\/s13005-020-00253-z","article-title":"Application value of combination therapy of periodontal curettage and root planing on moderate-to-severe chronic periodontitis in patients with type 2 diabetes","volume":"17","author":"Bian Y","year":"2021","unstructured":"Bian Y, Liu C, Fu Z. Application value of combination therapy of periodontal curettage and root planing on moderate-to-severe chronic periodontitis in patients with type 2 diabetes. Head Face Med. 2021, 17:12.","journal-title":"Head Face Med"},{"key":"ref195","doi-asserted-by":"publisher","DOI":"10.1016\/S0899-3467(07)60142-6","article-title":"Writing narrative literature reviews for peer-reviewed journals: secrets of the trade","volume":"5","author":"Green BN","year":"2006","unstructured":"Green BN, Johnson CD, Adams A. Writing narrative literature reviews for peer-reviewed journals: secrets of the trade. J Chiropr Med. 2006, 5:101-17. 10.1016\/S0899-3467(07)60142-6","journal-title":"J Chiropr Med"},{"key":"ref196","doi-asserted-by":"publisher","DOI":"10.1590\/0102-311X00063121","article-title":"The art and science of writing a scientific review article","volume":"37","author":"Vidal EI","year":"2021","unstructured":"Vidal EI, Fukushima FB. The art and science of writing a scientific review article. Cad Saude Publica. 2021, 37:e00063121. 10.1590\/0102-311X00063121","journal-title":"Cad Saude Publica"},{"key":"ref197","doi-asserted-by":"publisher","DOI":"10.4300\/JGME-D-22-00480.1","article-title":"Narrative reviews: flexible, rigorous, and practical","volume":"14","author":"Sukhera J","year":"2022","unstructured":"Sukhera J. Narrative reviews: flexible, rigorous, and practical. J Grad Med Educ. 2022, 14:414-7. 10.4300\/JGME-D-22-00480.1","journal-title":"J Grad Med Educ"},{"key":"ref198","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.864","article-title":"How to conduct a systematic review: a narrative literature review","volume":"8","author":"Jahan N","year":"2016","unstructured":"Jahan N, Naveed S, Zeshan M, Tahir MA. How to conduct a systematic review: a narrative literature review. Cureus. 2016, 8:e864. 10.7759\/cureus.864","journal-title":"Cureus"},{"key":"ref199","doi-asserted-by":"publisher","DOI":"10.4103\/ijamr.ijamr_234_22","article-title":"The art and science of writing narrative reviews","volume":"9","author":"Basheer A","year":"2022","unstructured":"Basheer A. The art and science of writing narrative reviews. Int J Adv Med Health Res. 2022, 9:124-6. 10.4103\/ijamr.ijamr_234_22","journal-title":"Int J Adv Med Health Res"},{"key":"ref200","doi-asserted-by":"publisher","DOI":"10.1111\/eci.12931","article-title":"Time to challenge the spurious hierarchy of systematic over narrative reviews?","volume":"48","author":"Greenhalgh T","year":"2018","unstructured":"Greenhalgh T, Thorne S, Malterud K. Time to challenge the spurious hierarchy of systematic over narrative reviews?. Eur J Clin Invest. 2018, 48:e12931. 10.1111\/eci.12931","journal-title":"Eur J Clin Invest"},{"key":"ref201","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2013.06.005","article-title":"Synthesizing evidence on complex interventions: how meta-analytical, qualitative, and mixed-method approaches can contribute","volume":"66","author":"Petticrew M","year":"2013","unstructured":"Petticrew M, Rehfuess E, Noyes J, et al.. Synthesizing evidence on complex interventions: how meta-analytical, qualitative, and mixed-method approaches can contribute. J Clin Epidemiol. 2013, 66:1230-43. 10.1016\/j.jclinepi.2013.06.005","journal-title":"J Clin Epidemiol"},{"key":"ref202","doi-asserted-by":"publisher","DOI":"10.1177\/135581960501000110","article-title":"Synthesising qualitative and quantitative evidence: a review of possible methods","volume":"10","author":"Dixon-Woods M","year":"2005","unstructured":"Dixon-Woods M, Agarwal S, Jones D, Young B, Sutton A. Synthesising qualitative and quantitative evidence: a review of possible methods. J Health Serv Res Policy. 2005, 10:45-53. 10.1177\/135581960501000110","journal-title":"J Health Serv Res Policy"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/269731-role-of-nonalcoholic-fatty-liver-disease-in-periodontitis-a-bidirectional-relationship","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T11:47:29Z","timestamp":1732362449000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/269731-role-of-nonalcoholic-fatty-liver-disease-in-periodontitis-a-bidirectional-relationship"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,3]]},"references-count":202,"URL":"https:\/\/doi.org\/10.7759\/cureus.63775","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,3]]}}}